Neurodiversity and Type 2 Diabetes Link Found in Youth

Study Connects Neurodiversity and Type 2 Diabetes in Youth

Young people diagnosed with type 2 diabetes (T2D) show higher rates of attention-deficit/hyperactivity disorder (ADHD) and autism than peers without the metabolic condition.

Researchers analyzed electronic health records from 4.2 million individuals diagnosed with T2D between March 2006 and March 2026. The dataset came from the TriNetX United States collaborative network.

The observational study was presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy. The work evaluated how neurodiversity and type 2 diabetes intersect across different age groups.

Prevalence Patterns Across Age Groups and Conditions

The highest prevalence of neurodivergent diagnoses appeared among patients diagnosed with T2D before age 20. In this group, ADHD was more than twice as common among individuals with T2D compared to matched controls (14.4% versus 6.9%).

Autism was more than three times as prevalent in patients diagnosed before age 20 with T2D compared to those without the condition (5.72% versus 1.79%). Overall, the study matched 3.4 million pairs younger than 80 by age, birth year, sex, race, and ethnicity.

The differences narrowed significantly in older age bands. For individuals diagnosed between ages 70 to 79, ADHD was present in 0.25% of the diabetes group versus 0.18% in the control group. Autism rates in that older bracket were below 0.01% in both cohorts.

• ADHD prevalence reached 14.4% in youths with diabetes compared to 6.9% in matched controls.
• Autism rates stood at 5.72% in youths with diabetes compared to 1.79% in the control group.
• People with T2D were roughly twice as likely to have dyslexia across age brackets.

Mechanisms Linking Neurodiversity and Type 2 Diabetes

Observational records cannot establish direct causation, but researchers identified several overlapping factors that may drive this relationship. Differences in physical activity, irregular sleep patterns, psychiatric medication use, and early-life variables may alter insulin sensitivity.

Sensory sensitivities and executive function challenges can also shape dietary intake. Irregular eating schedules or reliance on specific palatable foods can alter long-term glucose handling.

Lead author Dr. Jonathan Goldney of the University of Leicester Diabetes Research Center and National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Center emphasized that early-onset T2D brings longer lifetime exposure to metabolic strain.

Clinical Barriers for Neurodivergent Youth with Diabetes

Navigating standard clinical settings presents practical obstacles for neurodivergent individuals. Busy medical offices, sensory overload, and complex communication with staff can reduce clinic attendance.

Managing diabetes requires daily planning, carbohydrate counting, blood glucose checks, and medication schedules. These multi-step routines heavily tax executive function, which is often impaired in people with ADHD or autism.

These friction points can worsen metabolic control over time. Early-onset T2D, defined as diagnosis before age 40, already carries higher risks of cardiovascular complications and microvascular damage compared to late-onset disease.

What the Findings Mean for Metabolic Care

Health systems require clearer adaptations to support patients who balance cognitive differences with glucose management. Standard education materials often assume neurotypical executive function and predictable daily schedules.

Clinicians should consider sensory preferences and executive support when structuring dietary changes, glucose monitoring tools, and follow-up schedules. Simplified routines help prevent burnout in young adults managing both diagnoses.

Patients and families managing neurodiversity and type 2 diabetes can talk to their clinician about blood sugar screening and practical daily routines.